Revisiting cysteine protease function in Trypanosoma cruzi: implications for parasite egress and differentiation

Sara De Grandis1,2, Anne Niggli1, Delia Bogenstätter1

  • 1Institute of Cell Biology, University of Bern, Bern, Switzerland.

Microbiology Spectrum
|April 30, 2026
PubMed

Insights

Chagas disease parasite maturation and release are tightly controlled. Inhibiting cysteine proteases blocks parasite differentiation, leading to the release of immature, less infective forms, offering new drug targets.

Area of Science:

  • Parasitology
  • Cell Biology
  • Drug Discovery

Background:

  • Chagas disease affects millions globally with limited treatment options.
  • The life cycle of *Trypanosoma cruzi* involves complex host cell interactions.
  • Mechanisms of parasite differentiation and host cell exit are poorly understood.

Purpose of the Study:

  • To dissect the late stages of the *Trypanosoma cruzi* lytic cycle.
  • To investigate the role of cysteine proteases in parasite maturation and egress.
  • To establish a quantitative framework for drug discovery against Chagas disease.

Main Methods:

  • Real-time cellular impedance monitoring.
  • Stage-specific fluorescent parasite labeling.
  • Ultrastructural expansion microscopy.
  • Automated high-content imaging.

Main Results:

  • Trypomastigogenesis is coordinated with host cell egress.
  • Cysteine protease inhibition (Z-FA-FMK) impairs parasite maturation.
  • Inhibition leads to amastigote accumulation and release of immature trypomastigotes.

Conclusions:

  • Cysteine proteases are essential for *T. cruzi* differentiation and infectivity.
  • Inhibiting these proteases uncouples maturation from egress.
  • This study provides a platform for identifying new Chagas disease therapeutics.